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INTRODUCTION:  Primary  malignant  hepatic  mesotheliomas  are  extremely  rare.  We  report  the case  of  a
patient with  primary  intrahepatic  malignant  mesothelioma  who  was  treated  in  our  department.
PRESENTATION  OF CASE:  A 66-year  old  male patient  was  admitted  to our department  for  the  evaluation  of
anemia.  An  abdominal  computed  tomography  scan  revealed  a large  space  occupying  lesion  in  the  right
liver  lobe.
DISCUSSION:  The  tumor  was  subsequently  resected  and  a diagnosis  of  primary  intrahepatic  malignant
mesothelioma  was  made  after  pathologic  examination.  The  patient  did  not  receive  adjuvant  therapy  andntrahepatic
pithelioid type
is currently  alive  and free  of  disease,  36  months  after  the  resection.
CONCLUSION:  To  our  knowledge  this  is  the  eighth  adult  case  of  primary  intrahepatic  malignant  mesothe-
lioma  reported  in the  literature.  These  tumors  are  rarely  diagnosed  preoperatively.  Absence  of  previous
asbestos  exposure  does  not  exclude  malignant  mesothelioma  from  the differential  diagnosis.  Proper
surgical  treatment  may  offer  prolonged  survival  to the  patient,  without  adjuvant  therapy.
© 2014  Published  by Elsevier  Ltd.  on  behalf  of Surgical  Associates  Ltd.  This  is an  open  access  article
he CCunder  t
. Introduction
Mesothelioma is an insidious neoplasm arising from the
esothelial surfaces of the pleural and peritoneal cavities, the
unica vaginalis, or the pericardium. Eighty percent of all cases are
leural in origin. The predominant cause of malignant mesothe-
ioma is inhalational exposure to asbestos. The annual incidence of
esothelioma in the United States is estimated to be approximately
300 cases per year.1 Primary malignant mesotheliomas arising in
he liver are extremely rare. We  present the case of a 66-year old
ale patient with primary intrahepatic malignant mesothelioma
ho was treated in our department.
. Presentation of case
A 66-year old male patient was referred to our department
n November 2011 with a history of malaise during the previ-
us two months. The patient’s medical history was  signiﬁcant
nly for arterial hypertension, being treated with two  antihy-
ertensive drugs. The patient had no history of prior asbestos
xposure or chronic liver disease. Previous laboratory examina-
ions had revealed anemia (Hb = 8.5 g/dL, Hct% = 29.3%) and the
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patient had received oral iron supplementation for two  months
with no improvement. Colonoscopy and gastroscopy had no sig-
niﬁcant ﬁndings, apart from mild gastritis and hemorrhoids.
Upon presentation, physical examination revealed a palpa-
ble mass in the right upper abdomen. There were no signs of
jaundice or abdominal tenderness. Signiﬁcant results of labora-
tory tests on admission were as follows: hemoglobin = 7.5 g/dL,
hematocrit = 23.8%, INR = 1.4, alkaline phosphatase (ALP) = 227 IU/L
(normal range 40–150), total proteins = 9.1 g/dL (normal range
6.7–8.8), albumin = 2.3 g/dL (normal range 3.5–5), C-reactive
protein = 67 mg/L (normal range <5), carcinoembryonic antigen
(CEA) = 1.9 g/L (normal range <5), a-fetoprotein (AFP) = 2.4 g/L
(normal range <20), Ca19-9 <2 U/mL (normal range <37),
Ca125 = 259.7 U/mL (normal range <35), Ca15-3 = 69 U/mL (normal
range <30). The rest of the laboratory examinations were within
normal range.
The patient underwent computed tomography of the chest and
abdomen, which revealed an extensive space occupying lesion
in the right liver lobe, measuring 17 cm in diameter. The tumor
displayed abnormal enhancement following intravenous adminis-
tration of contrast material (Figs. 1 and 2). A core needle biopsy
which was  performed was  not helpful as it contained only necrotic
material without evidence of malignancy.On November 7, 2011 the patient underwent exploratory
laparotomy which revealed a sizable mass in the right liver lobe
without evidence of metastatic disease in the abdomen. A typi-
cal right hepatectomy was undertaken. In the ﬁrst postoperative
s Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 3. Macroscopic view of the surgical specimen, showing a large intraparenchy-
mal  tumor of the right liver lobe.
Fig. 4. Irregular cystic and tubular spaces lined by a single layer of mesothelial cells
or  compact pattern of anastomosing cords of neoplastic cells.ig. 1. Computed tomography showing an ill deﬁned, intraparenchymal tumor
bliterating most of the right lobe of the liver (transverse section).
ay liver function tests revealed a sudden increase in bilirubin and
ransaminases levels, which was attributed to hemolysis and tran-
ient liver failure. Liver function tests returned progressively to
ormal and the patient was discharged on the seventh postopera-
ive day.
On gross examination the lobectomy specimen was massively
nﬁltrated by a brown, partly hemorrhagic tumor, with soft con-
istency, measuring 18 × 15.5 × 8 cm,  extending to the capsular
urface (Fig. 3). Microscopically, the tumor was composed of tubu-
ar or cord like arrangements of epithelioid cells with eosinophilic
ytoplasm and atypical nuclei (Fig. 4). Immunohistochemically,
umor cells were positive for EMA, CK-7, CK 5/6, Calretinin
Fig. 5), Pankeratin and Vimentin, but negative for CEA (mono-
lonal), P-63, CD-10, CK-20, Synaptophysin, Chromogranin, CD-56,
TF-1, HepPar-1, HBsAg, CD-15, CD-30, PLAP and -HCG. Immuno-
istological analysis of the proliferation marker Ki-67 showed
xpression in 15–20% of the tumor cells. These ﬁndings were
onsistent with our diagnosis of primary intrahepatic malignant
esothelioma of the epithelioid type. Resection margins were free
f disease.
After oncology consultation, the patient did not receive adjuvant
hemotherapy postoperatively. He remains alive and free of disease
6 months after the operation.
. DiscussionPrimary intrahepatic malignant mesotheliomas are extremely
are. To our knowledge this is the eighth adult case of primary
ntrahepatic malignant mesothelioma reported in the literature.2–8
here have been reports of mesotheliomas originating in the
ig. 2. Computed tomography showing an ill deﬁned, intraparenchymal tumor
bliterating most of the right lobe of the liver (coronal section).
Fig. 5. Antibody against calretinin is the most speciﬁc and reproducible positive
marker of epithelioid mesothelioma. Cells labeled by the antibody display both a
cytoplasmic and a nuclear staining pattern.
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falciform ligament9 or the liver surface,10 which probably represent
peritoneal mesotheliomas involving the liver.
Three different characteristic histological patterns can be
discriminated based on routine hematoxylin–eosin staining:
epithelioid, sarcomatoid and biphasic. Six cases (including ours)
out of eight reported in the literature, were of the epithelioid type,
while two were of the biphasic type.
In detail, there were four men  and three women, aged between
50 and 68 years old. Five patients had no history of asbestos
exposure, one patient had occupational exposure to asbestos and
pulmonary asbestosis and in another case there was no indication.
One patient without asbestos exposure had chronic hepatitis C.
Tumor size ranged between 3.2 and 16 cm.  All patients except from
one had solitary lesions. Seven patients were surgically treated. In
one patient hepatic rupture occurred due to rapid tumor growth
with consequent clinical deterioration, thus not allowing surgi-
cal resection. Another patient developed subsequent lymph node
metastases and was treated with repeated lymphadenectomy,
resulting in prolonged survival.4,11 No clinical or radiological evi-
dence of recurrent disease has been detected in our patient up to
36 months following resection. Table 1 summarizes the seven cases
of primary intrahepatic malignant mesotheliomas reported in the
literature.
4. Conclusion
In conclusion malignant mesothelioma of the liver is rarely diag-
nosed preoperatively, as there are no speciﬁc radiologic features for
this tumor. Absence of previous asbestos exposure does not exclude
malignant mesothelioma from the differential diagnosis. Proper
surgical treatment may  offer prolonged survival to the patient,
without adjuvant therapy.
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